Navigation Links
9/11 Responders May Be At Raised Myeloma Risk
Date:8/10/2009

Cases are appearing at a younger age than is normal, researchers note

MONDAY, Aug. 10 (HealthDay News) -- Preliminary findings suggest that responders to the attacks on the Twin Towers on 9/11 may be at higher risk for multiple myeloma, a cancer of the blood.

Notably, half of the cases identified among law enforcement officers were under the age of 45. Multiple myeloma is usually a disease of the elderly.

"This is very preliminary," cautioned Dr. Mitchell Smith, director of the Lymphoma Service at Fox Chase Cancer Center in Philadelphia. "It could turn out to be a statistical fluke and means nothing or it could be the tip of the iceberg and we'll see an increase in the next 10 years," he said.

"The concerning thing," he added, "is it makes biological sense. There is certain data that multiple myeloma is associated with an increased exposure to certain chemicals. It has never been shown with inhaled chemicals but this amount of exposure probably did get into the blood." Smith was not involved in the study.

"Practitioners should be on the lookout for unusual disease patterns," added Dr. Jacqueline Moline, lead author of the report, which appears in the August issue of the Journal of Occupational and Environmental Medicine. "Multiple myeloma is usually a disease that occurs in the seventh or eighth decade of life. A person is 10 times more likely to get myeloma when they're 70 than when they're 45 or 48. Clinicians should be sensitized to patients coming in with unusual symptoms. They should think broadly."

And that includes being on the alert for other types of cancers as well, added Moline, who is director of the World Trade Center Medical Monitoring and Treatment Program at Mount Sinai School of Medicine in New York City. "Time is really going to give us the answer in terms of other exposures," she said.

Rescue workers were heavily exposed to a toxic chemical soup released f
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. September 11th First Responders Lead Emotional Rally at State Capitol Tuesday
2. Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders
3. Emergency responders at high risk to miss work because of injuries
4. Pulmonary Fibrosis Patients/9/11 Responders Represented at State of the Union Address for Second Year in a Row
5. First Responders Acquire Revolutionary MyClyns(TM) Protective Spray
6. Iridium(R) Satellite, ProtectingAmerica.org and the American Red Cross Partner to Educate First Responders on Importance of Testing Satellite Phones
7. Specialized white blood cells coordinate first responders to viral infection
8. Lung Problems Persist for 9/11 Responders
9. University of Rochester Launches iTraining for Emergency Responders
10. Raytheon to Provide California First Responders and Healthcare Personnel Electronic Patient Tracking System
11. Kidney Awareness Time (KAT) Walk Raised Awareness and $400,000 for Kidney Education and Prevention Programs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
9/11 Responders May Be At Raised Myeloma Risk
9/11 Responders May Be At Raised Myeloma Risk
Breaking Medicine Technology:Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 2Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 3VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 3GenVec Announces Registered Offering of 246 Million in Common Stock and Warrants 13717 1GenVec Announces Registered Offering of 246 Million in Common Stock and Warrants 13717 2GenVec Announces Registered Offering of 246 Million in Common Stock and Warrants 13717 3Dendreon Announces Analyst Day Webcast Presentation to be Held on September 24 2009 13716 1Memorial Blood Centers in Urgent Need of Type O Negative and Type B Negative Blood Donors 55487 1Memorial Blood Centers in Urgent Need of Type O Negative and Type B Negative Blood Donors 55487 2